FDA Inspection 1251796 — Molecular Imaging Program At Stanford
The FDA completed an inspection of Molecular Imaging Program At Stanford on Oct 4, 2024 in Palo Alto, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 4, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palo Alto, CA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1 | 21 CFR 11 | Electronic records |
| 17764 | 21 CFR 212.20(e) | Written QA procedures established, followed |
| 17853 | 21 CFR 212.60(d) | Supplies adequately controlled |